cbdc campbellton See results about

The New Zealand dollar just broke through the 0.5800 mark against the US dollar, and the latest report was 0.5801, up 0.29% in the day; The Australian dollar just broke through the 0.6400 mark against the US dollar, and the latest report was 0.6401, up 0.51% in the day.CITIC Jiantou: With the continuous promotion of new power system construction, the growth attribute of green power is expected to be highlighted. CITIC Jiantou Research Report said that recently, the National Energy Administration issued the "Guiding Opinions on Supporting the Innovation and Development of New Business Entities in the Power Field", proposing that new business entities should be exempted from applying for power business licenses and exploring the mechanism of establishing new energy direct connection to increase the supply of green power for enterprises. Specifically, the new business entities include distributed power supply, adjustable load, virtual power plant and smart microgrid. At present, the installed capacity of new energy in China is growing rapidly. Due to the restriction of power grid access capacity, the problem of power abandonment is on the rise. The mechanism of direct connection of new energy enterprises is helpful to improve the ability of local consumption of new energy, reduce the abandonment of wind and light, and promote the improvement of project yield. Generally speaking, with the continuous promotion of new power system construction, the profitability of new energy power generation projects is expected to improve marginally, and the growth attribute of green power is expected to be highlighted.Australia's ASX 200 index narrowed to 0.1%, and the Australian dollar increased. The just released Australian employment data was better than expected.

The restricted shares with a market value of 2.546 billion yuan were lifted today. Yongda, Sitaili and Dameng Data were among the top companies in terms of market value. On Thursday (December 12), the restricted shares of 8 companies were lifted, with a total lifting amount of 175 million shares. According to the latest closing price, the total lifting market value was 2.546 billion yuan. Judging from the amount of lifting the ban, the number of shares lifted by the two companies exceeded 10 million. Si Taili, Yongda and Ningxin New Materials were among the top, with 95,895,400 shares, 65,203,300 shares and 6,633,200 shares respectively. Judging from the market value of lifting the ban, the number of shares lifted by the two companies exceeded 100 million yuan. Yongda Co., Ltd., Sitaili and Dameng Data are among the top companies in terms of market value, with market values of 1.039 billion yuan, 992 million yuan and 349 million yuan respectively. Judging from the proportion of shares released from the ban to the total share capital, the proportion of the two companies released from the ban exceeded 10%. Yongda Co., Ltd., Sitaili Co., Ltd. and Ningxincai Co., Ltd. have the highest proportion of lifting the ban, accounting for 27.17%, 21.87% and 7.13% respectively.18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.South Korean President Yin Xiyue: The opposition party does not recognize the president.

Huatai Securities: It is expected that the Fed will cut interest rates by 25bp in December, but the path of interest rate cut in 2025 is highly uncertain. Huatai Securities said that the overall inflation in November in the United States was in line with expectations, and the slight cooling of service inflation partially eased the market's concerns about inflation rebound. It is expected that the Fed will cut interest rates by 25bp in December, but the path of interest rate cut in 2025 is highly uncertain. Recently, the overall economic momentum of the United States has rebounded: from September to November, the PMI of Markit manufacturing in the United States has rebounded for three consecutive months; After the election, enterprises, especially small enterprises, are expected to improve, and the recent NFIB SME confidence index has rebounded significantly; The latest Atlanta GDP Now shows that the fourth quarter GDP growth rate of the United States is 3.3% year-on-year. However, considering that the unemployment rate data rebounded in November, and the recent inflation is still relatively moderate, we expect that the recent data may not prevent the Fed from cutting interest rates at its December meeting next week. However, in 2025, the growth and inflation path of the United States was disturbed by the Trump policy, and the Federal Reserve may "make a camera choice" on the basis of watching the overall economic trend. There is uncertainty in the path of interest rate cut in 2025.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.The Nikkei 225 index hit a two-month high of 40,000 points, and the Nikkei 225 index hit a two-month high of 40,000 points, up 1.61% in the day.